Form 8-K - Current report:
SEC Accession No. 0000874716-22-000028
Filing Date
2022-07-15
Accepted
2022-07-15 16:59:48
Documents
15
Period of Report
2022-07-13
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K idxx-20220713.htm   iXBRL 8-K 40505
2 EX-3.2 exhibit32-idxxarbyxlaws.htm EX-3.2 240288
7 idxx-20220713_g1.jpg GRAPHIC 39045
  Complete submission text file 0000874716-22-000028.txt   576087

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT idxx-20220713.xsd EX-101.SCH 2250
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT idxx-20220713_def.xml EX-101.DEF 15619
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT idxx-20220713_lab.xml EX-101.LAB 30216
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT idxx-20220713_pre.xml EX-101.PRE 16251
9 EXTRACTED XBRL INSTANCE DOCUMENT idxx-20220713_htm.xml XML 12119
Mailing Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041
Business Address ONE IDEXX DRIVE WESTBROOK ME 04092-2041 2075560300
IDEXX LABORATORIES INC /DE (Filer) CIK: 0000874716 (see all company filings)

EIN.: 010393723 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19271 | Film No.: 221087469
SIC: 2835 In Vitro & In Vivo Diagnostic Substances